These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 6814882)

  • 21. Tocainide: a new drug for ventricular arrhythmias.
    Volosin KJ; Greenspon AJ
    Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
    Roden DM
    Postgrad Med; 1985 Sep; 78(4):28-37. PubMed ID: 2412217
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiarrhythmic drug therapy of ventricular arrhythmias.
    Huang SK; Marcus FI
    Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 25. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy with investigational antiarrhythmic drugs.
    Mead RH; Harrison DC
    Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M
    Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electrophysiologic and clinical study of tocainide, a new class IB drug].
    Vergara G; Disertori M; Bettini R; Stirpe E; Gramegna L; Furlanello F
    Minerva Cardioangiol; 1986 Nov; 34(11):711-9. PubMed ID: 3101001
    [No Abstract]   [Full Text] [Related]  

  • 31. Tocainide.
    Hanyok JJ
    Conn Med; 1985 Dec; 49(12):827-8. PubMed ID: 3936674
    [No Abstract]   [Full Text] [Related]  

  • 32. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine.
    Alpert JS; Haffajee CI; Young MD
    Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 35. Ventricular arrhythmias: current concepts.
    Nestico PF; Morganroth J
    Compr Ther; 1984 Sep; 10(9):32-6. PubMed ID: 6435947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
    Bernard R; Renard M; Shita A; de Hemptinne J; Gillet JM; Lewinson H; Liebens I; Waterschoot P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):195-8. PubMed ID: 3090925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perspectives in anti-arrhythmia pharmacological therapy].
    Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M
    Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic therapy: new additions and future expectations.
    Ross WB; Mohiuddin SM
    Geriatrics; 1983 Jan; 38(1):30-5. PubMed ID: 6184263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.